Beauty Health (NASDAQ:SKIN) Coverage Initiated by Analysts at TD Cowen

Posted by George Bondi on Oct 31st, 2026

Equities research analysts at TD Cowen started coverage on shares of Beauty Health (NASDAQ:SKIN – Get Free Report) in a research note issued on Friday, Zacks reports. The firm set a “hold” rating on the stock.

Other equities research analysts also recently issued research reports about the company. Jefferies Financial Group restated a “hold” rating and set a $11.00 price target (up from $0.85) on shares of Beauty Health in a report on Monday, October 19th. Stifel Nicolaus set a $10.00 price target on Beauty Health in a research report on Thursday, October 15th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Beauty Health in a research note on Wednesday, October 21st. Citigroup reissued a “hold” rating on shares of Beauty Health in a research report on Thursday, October 15th. Finally, Canaccord Genuity Group set a $11.00 target price on shares of Beauty Health and gave the stock a “hold” rating in a research note on Thursday, October 22nd. One analyst has rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $18.00.

Get Our Latest Stock Analysis on SKIN

Beauty Health Stock Performance

NASDAQ:SKIN opened at $9.94 on Friday. Beauty Health has a 52 week low of $9.68 and a 52 week high of $34.80. The company has a fifty day simple moving average of $12.48 and a two-hundred day simple moving average of $16.85. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36. The company has a market cap of $64.68 million, a price-to-earnings ratio of -2.26 and a beta of 1.05.

Beauty Health (NASDAQ:SKIN – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.40) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.50) by $0.10. The business had revenue of $72.11 million for the quarter, compared to analysts’ expectations of $74.45 million. Beauty Health had a negative return on equity of 47.83% and a negative net margin of 9.79%. As a group, equities analysts anticipate that Beauty Health will post -3.18 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

A hedge fund recently raised its stake in Beauty Health stock. Bank of America Corp DE raised its stake in The Beauty Health Company (NASDAQ:SKIN – Free Report) by 19.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 106,242 shares of the company’s stock after acquiring an additional 17,088 shares during the period. Bank of America Corp DE owned 0.08% of Beauty Health worth $95,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 93.26% of the stock is owned by hedge funds and other institutional investors.

Beauty Health Company Profile

(Get Free Report)

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.